文献速递耳科与耳神经

Sentio骨导植入体:传导性或混合性听力损失的早期结局

Sentio Bone-Conduction Implant: Early Outcomes in Patients With Conductive or Mixed Hearing Loss.
PubMed 文献 · Laryngoscope · 2026-06-22

本研究评估2024年获批的Sentio主动骨导植入体在28例传导性或混合性听力损失患者中的早期临床结局、安全性和听力疗效。结果显示手术无并发症,纯音阈值和言语识别显著改善,APHAB问卷得分下降,提示该装置安全有效。

要点

  • Sentio植入后平均纯音阈值从56.3 dB HL(未助听)改善至25.3 dB HL。
  • 言语识别率从术前11.9%(未助听)提升至随访时93.3%。
  • APHAB全局得分从53.2分降至32.6分,主观获益明显。

核心结论

  • Sentio植入对传导性或混合性听力损失的康复有效且安全,早期结果支持其作为可靠的骨导听力解决方案。

研究设计与样本

  • 前瞻性研究,纳入28例患者(10例传导性、18例混合性听力损失),植入Sentio并随访至激活后1个月。

主要发现

  • 所有手术无并发症,1例需修正手术并成功,无其他不良事件。
  • 平均纯音阈值从56.3 dB HL(未助听)和31.7 dB HL(Ponto软带)改善至激活后25.3 dB HL,1个月随访稳定(p < 0.001)。
  • 言语识别率从术前11.9%(未助听)和85.5%(Ponto)提升至激活时87.3%、随访时93.3%(p < 0.001)。
  • 噪声下言语感知信噪比从术前+1.97 dB(未助听)和2.22 dB(助听)改善至激活时-2.04 dB、随访时-2.67 dB(p < 0.001)。
  • APHAB全局得分从术前53.2分降至术后32.6分(p < 0.001)。

临床怎么用

  • 对于传导性或混合性听力损失患者,Sentio可作为一种有效的主动骨导植入选择,短期内可显著改善听阈和言语识别。

局限性

  • 样本量较小(28例),随访时间短(仅至激活后1个月),需更长期和大样本研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Sentio (Oticon Medical) is an active bone-conduction implant approved in 2024. This study evaluates initial clinical outcomes, safety, and audiological efficacy of the Sentio in patients with conductive or mixed hearing loss. METHODS: A total of 28 patients (10 conductive, 18 mixed hearing loss) were implanted with Sentio. Preoperative assessments included pure-tone audiometry and speech recognition testing in unaided and aided conditions. Postoperative evaluations of hearing thresholds and speech recognition were performed in free field. Subjective benefit was assessed using the APHAB questionnaire before and after implantation. The first follow-up occurred 1 month after activation. RESULTS: All surgeries were completed without complications. One patient required revision surgery, which was successful. No other adverse events occurred. Mean hearing threshold improved from 56.3 dB HL (unaided) and 31.7 dB HL with Ponto on a softband to 25.3 dB HL post-activation and remained stable at 1-month follow-up (p < 0.001). Speech discrimination was 11.9% preoperatively (unaided) and 85.5% with Ponto. It reached 87.3% at activation and 93.3% at the follow-up (p < 0.001). Speech perception in noise was +1.97 dB SNR before implantation (unaided) and 2.22 dB SNR (aided), -2.04 dB SNR at implant activation and -2.67 dB SNR at the follow-up (p < 0.001 for implant conditions vs. unaided). APHAB global score decreased from 53.2 points preoperatively to 32.6 points postoperatively (p < 0.001). CONCLUSION: Sentio implantation appears effective and safe for the rehabilitation of conductive or mixed hearing loss. The first clinical results demonstrate audiological improvement and subjective benefit, supporting the potential of the system as a reliable bone-conduction hearing solution.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Cywka KB, Skarzynski PH, Baczyk M, et al. Sentio Bone-Conduction Implant: Early Outcomes in Patients With Conductive or Mixed Hearing Loss. Laryngoscope. 2026. PMID: 42332362. doi:10.1002/lary.70704

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。